The AIDS Clinical Trials Unit at the University of Southern California at 5P21/Rand Schrader Clinic was established in 1986 as a center for state-of-the-art HIV/AIDS clinical trials. The University of Southern California's designation as an AIDS Clinical Trials Unit (ACTU) makes it part of the world's largest organization involved in HIV/AIDS clinical trials research, the AIDS Clinical Trials Group, a nationwide network. This group has been instrumental in setting standards of care for treatment of HIV and its complications throughout the world. Funding in part comes from a grant provided by the National Institute of Health, Division of Allergies and Infectious Diseases, Division of AIDS.
The ACTU at the University of Southern California is dedicated to offering the latest in research clinical trials to HIV/AIDS patients throughout Southern California. The Unit also participates in trials supported by private pharmaceutical sponsors and studies designed by USC investigators.
The University of Southern California at the 5P21/Rand Schrader Clinic is an AIDS Clinical Trials Unit. Part of the International AIDS Clinical Trials Group (ACTG), it is sponsored by the National Institutes of Health, Division of Allergy and Infectious Diseases, Division of AIDS. The ACTG is currently made up of more than 30 individual ACTU's across the United States and Puerto Rico as well as international sites in Europe, South America, and Asia. It is the largest HIV/AIDS clinical trials research organization in the world. The ACTG is made up of both clinical and basic science research sites with a common goal: improving the treatment and care of those living with HIV.
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.